Find resistance through surveillance and source tracing with two new tools: PointFinder and ShortBRED Winnie Ridderberg, PhD, Senior Scientist, Microbial...

As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across...

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One...

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support We are excited to announce our acquisition N-of-One,...

[metaslider id=19676] With great networking opportunities, exciting panel discussions, and a packed exhibit hall, Precision Medicine World Conference 2019 was...

Visualize, analyse, explore, and share with greater ease We are delighted to introduce the new CLC Genomics Workbench 12 –...

Need access to 75,000+ human ‘omics datasets for your oncology-research? Discover a world of oncology-focused datasets, analysis tools, and biomarker...

Searching for new biomarkers for your NGS panel and assay design? Discover a world of disease-focused datasets, analysis tools, and...

HGMD® Professional version 2018.4 contains a total of 248,700 mutations entries—that’s 8,431 more mutation entries than the previous release! Unlike other...

Introducing a novel myeloid gene panel for the GeneReader NGS System with integrated variant analysis, interpretation and reporting from QIAGEN...